Compare
CVS Health vs Labcorp (CVS vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year CVS Health (CVS) returned +6.8% and Labcorp (LH) +46.2%; so far this year the figures are +5.7% and +46.1%.
CVS Health is the larger company by market value, about 3.6 times the size of Labcorp.
On trailing earnings, CVS trades at 9.7 times and LH at 30.1 times.
Revenue grew +6.7% at CVS and +6.0% at LH over the last year.
CVS yields 3.17%. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| CVS | LH | |
|---|---|---|
| Price | $83.85 | $366.57 |
| 1-day | +3.10% | +0.90% |
| YTD | +5.66% | +46.11% |
| 1 year | +6.75% | +46.22% |
| 3 years | +22.00% | +79.74% |
| Market cap | $107.3B | $29.8B |
| P/E | 9.7 | 30.1 |
| P/S | 0.26 | 2.04 |
| P/B | 1.33 | 3.36 |
| Revenue growth | +6.70% | +6.00% |
| EPS growth | +2107.70% | +19.60% |
| Gross margin % | 44.2 | 29.0 |
| Net margin % | 2.6 | 6.9 |
| ROE % | 13.7 | 11.3 |
| Debt / equity | 0.75 | 0.66 |
| FCF yield % | 14.5 | 4.3 |
| Dividend yield % | 3.17 | 0.79 |
| Beta | -0.06 | 0.38 |
| RSI (14) | 39.9 | 69.9 |
| Technical rating |